French drug major Sanofi (SNYNF,SNY) announced Tuesday a collaboration with Formation Bio and AI research and deployment company OpenAI to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently.
Under the deal, the companies would bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle.
Sanofi said it will leverage the partnership to provide access to proprietary data to develop AI models as it continues on its path to becoming the first biopharma company powered by AI at scale.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.